-- Jula Inrig, Chief Medical Officer, on May 04, 2026, sold 22,485 shares in Travere Therapeutics (TVTX) for $1,015,086. Following the Form 4 filing with the SEC, Inrig has control over a total of 113,238 common shares of the company, with 113,238 shares held directly.
SEC Filing: